The impact of genetic background on mouse models of disease

被引:19
|
作者
Bufi, Rei [1 ]
Korstanje, Ron [1 ,2 ]
机构
[1] Jackson Lab, Bar Harbor, ME USA
[2] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
基金
美国国家卫生研究院;
关键词
genetic background; genetic diversity; kidney disease; mouse model; translational research; ACUTE KIDNEY INJURY; DIABETIC-NEPHROPATHY; MURINE MODEL; AGING MICE; C57BL/6; HYPERTENSION; ALBUMINURIA; CISPLATIN; GLOMERULOSCLEROSIS; SUSCEPTIBILITY;
D O I
10.1016/j.kint.2022.03.020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The mouse is the most commonly used mammalian model to study disease, including kidney disease. However, close attention needs to be paid to the differences and effects of genetic background. The default choice of most investigators is to use C57BL/6 mice, but not all C57BL/6 mice are the same. Ever since the C57BL/6 line was first established, differences in the genetic background have risen between substrains, which have major implications in the phenotypes expressed in kidney disease. Furthermore, considering that C57BL/6 substrains are relatively resistant to kidney damage, there can be major benefits in selecting other mouse inbred strains when studying kidney disease. These strains can show more similar responses regarding kidney damage as in humans, and results may therefore translate better to human application. Genetically diverse mice, such as the Diversity Outbred mice, allow investigators to study kidney phenotypes with comparable levels of genetic diversity as seen in humans, which yield results that more closely reflect the variation in human disease outcomes due to genetic variation. Hence, embracing the genetic diversity that is present in mice can lead to better translational research methods. Investigators need to always take into consideration that genetic background is a variable that can alter results significantly, and optimization of translational research asks for careful strain selection and more rigorous reporting of the genetic background that is being used in experiment.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [1] The impact of genetic background on cancer phenotypes of mouse models
    Begley, Dale A.
    Krupke, Debra M.
    Neuhauser, Steven B.
    Jocoy, Emily L.
    Sundberg, John P.
    Bult, Carol J.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] The impact of genetic background in mouse and rat models: concerns and solutions
    Benavides, Fernando
    TRANSGENIC RESEARCH, 2013, 22 (01) : 211 - 211
  • [3] Genetic background and tumour susceptibility in mouse models
    Puccini, J.
    Dorstyn, L.
    Kumar, S.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (07): : 964 - 964
  • [4] Genetic background and tumour susceptibility in mouse models
    J Puccini
    L Dorstyn
    S Kumar
    Cell Death & Differentiation, 2013, 20 : 964 - 964
  • [5] Mutation Position and Genetic Background Modulate Disease Expression in Pkhd1 Mouse Models
    Odinakachukwu, Maryanne
    Yang, Chaozhe
    Bebok, Zsuzsanna M.
    Guay-Woodford, Lisa M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 397 - 397
  • [6] Effects of genetic background on disease phenotypes in a mouse model of Fabry disease
    Jabbarzadeh-Tabrizi, Siamak
    Day, Taniqua
    Taroua, Mouna
    Boutin, Michel
    Auray-Blais, Christiane
    Schiffmann, Raphael
    Shen, Jin-Song
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S79 - S79
  • [7] The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases
    Linder, CC
    LAB ANIMAL, 2001, 30 (05) : 34 - 39
  • [8] Protective effect of copaxone in mouse models of ALS depends on genetic background and gender
    Ludolph, AC
    Schwalenstoecker, B
    Danzeisen, R
    Waibel, S
    ANNALS OF NEUROLOGY, 2004, 56 : S21 - S21
  • [9] Mouse models of human genetic disease: Which mouse is more like a man?
    Erickson, RP
    BIOESSAYS, 1996, 18 (12) : 993 - 998
  • [10] Genetic mouse models of Parkinson's disease: The state of the art
    Magen, Iddo
    Chesselet, Marie-Francoise
    RECENT ADVANCES IN PARKINSONS DISEASE: TRANSLATIONAL AND CLINICAL RESEARCH, 2010, 184 : 53 - 87